Table 3.
Comparison of parameters between 30‐day morality (+) and 30‐day morality (−) patients
| 30‐day morality (+) (n = 13) | 30‐day morality (−) (n = 141) | P value | |
|---|---|---|---|
| Age (year) | 62.54 ± 16.90 | 56.60 ± 14.80 | .272 |
| Sex (male/female) | 6/7 | 75/66 | .627 |
| NE (×109/L) | 13.95 ± 5.97 | 8.53 ± 3.80a | .007 |
| LY (×109/L) | 1.49 ± 0.68 | 1.34 ± 0.66 | .640 |
| PLT(×109/L) | 176.00 ± 50.55 | 211.28 ± 59.99 | .539 |
| NLR | 12.07 ± 10.69 | 8.90 ± 8.91 | .781 |
| PLR | 142.77 ± 78.23 | 211.98 ± 170.41 | .246 |
| D‐dimer (ng/mL) | 4486.15 ± 4451.74 | 3758.24 ± 7318.80 | .822 |
| RDW (%) | 14.53 ± 1.61 | 13.68 ± 1.45 | .802 |
| cTnI (+) | 12/1 | 51/90b | .000 |
| NT‐proBNP (+) | 12/1 | 54/87b | .000 |
NE = neutrophil granulocyte, LY = leukomonocyte, PLT = platelet, NLR = neutrophil‐to‐lymphocyte ratio, PLR = platelet‐to‐lymphocyte ratio, RDW = red cell distribution width, cTnI = cardiac troponin I, NT‐proBNP = N‐terminal pro‐brain natriuretic peptide.
a
P < .05 compared with 30‐day mortality (−) patients.
b
P < .01 compared with 30‐day mortality (−) patients.